# EDGAR Filing Document

**Accession Number:** 0001596967
**File Stem:** 0001193125-26-191621
**Filing Date:** 2026-4
**Character Count:** 44019
**Document Hash:** 95f1395be6d63aa2275cc57a6789ed9e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-191621.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001193125-26-191621

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260429

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Moelis & Co
- **CENTRAL INDEX KEY:** 0001596967
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 464500216
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36418
- **FILM NUMBER:** 26916238

**BUSINESS ADDRESS:**
- **STREET 1:** 399 PARK AVENUE, 5TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** (212) 883-3800

**MAIL ADDRESS:**
- **STREET 1:** 399 PARK AVENUE, 5TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** April 29, 2026<br>

------

![img35465623_0.gif](img35465623_0.gif)

Moelis & Company

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-36418 | 46-4500216 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 399 Park Avenue<br>4th Floor |  |  |
| New York**,** New York |  | 10022 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** 212 883-3800<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Class A Common Stock | MC | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 2.02 Results of Operations and Financial Condition.
On April 29, 2026, Moelis & Company issued a press release announcing financial results for the first quarter ended March 31, 2026.

A copy of the press release is attached hereto as Exhibit 99.1. All information in the press release is furnished but not filed.

## Item 7.01 Regulation FD Disclosure.
On April 29, 2026, Moelis & Company (the "Company") updated the investor presentation available under "Events and Presentations" on the Investor Relations section of its website. The updated presentation is available using the following link: http://investors.moelis.com/event. The information in this Item 7.01 of this Form 8-K is furnished as of the date hereof, and the Company disclaims any obligation to correct or update this information, its website or the presentation in the future. The contents of the Company's website are not included or incorporated by reference into this Form 8-K, and any references to such website are intended to be inactive textual references only. All information in this Item 7.01 of this Form 8-K is furnished but not filed.

## Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 99.1 | [<u>Press release of Moelis & Company dated April 29, 2026</u>](mc-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | MOELIS & COMPANY |
| Date: | April 29, 2026 | By:  | /s/ Christopher Callesano |
|  |  |  | Name: Christopher Callesano<br>Title: Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

![img34168335_0.gif](img34168335_0.gif)

**Moelis & Company Reports First Quarter 2026 Financial Results;** 

**Declares Regular Quarterly Dividend of $0.65 Per Share**

• Record first quarter revenues of $319.8 million, up 4% from the prior year period

• GAAP net income of $0.48 per share (diluted) for the first quarter of 2026; Adjusted net income of $0.50 per share (diluted) for the first quarter of 2026; GAAP and Adjusted net income includes a $0.11 per share (diluted) tax benefit

• First quarter 2026 Adjusted pre-tax margin of 15.0% vs. 14.0% in the prior year period

• Continued to execute on our growth strategy:

―Since our last earnings release, one Managing Director focused on private credit secondaries and one focused on Healthcare have joined the Firm

―Six additional Managing Directors are committed to join throughout the year, including two hires in Capital Markets, two hires in London focused on Chemicals and Sponsors, and two hires in Energy and Private Capital Advisory

• Strong balance sheet with cash and short-term investments of $353.7 million and no debt

―Declared regular quarterly dividend of $0.65 per share

―Repurchased 1.9 million shares during the first quarter, including a quarterly record 0.9 million open market repurchases at an average price of $59.78 per share

―Including the dividend declared today, we will have returned $171.4 million to shareholders with respect to the first quarter of 2026

NEW YORK, April 29, 2026 – Moelis & Company (NYSE:MC) today reported financial results for the first quarter ended March 31, 2026. The Firm's first quarter revenues of $319.8 million increased 4% from the prior year period. The Firm reported first quarter GAAP net income of $42.3 million, or $0.48 per share (diluted). On an Adjusted basis, the Firm reported net income of $43.1 million and $0.50 per share (diluted) for the first quarter of 2026, as compared with net income of $54.4 million, or $0.64 per share (diluted), in the prior year period. GAAP and Adjusted net income in the first quarter of 2026 include a net tax benefit of approximately $0.11 per share (diluted) related to the settlement of share-based awards.

"We reported record first quarter revenues and advised our clients on a record level of first quarter announced transaction activity. With our pipeline near all-time highs, our Firm is positioned for continued strong performance. We remain focused on delivering for our clients, investing in our people, and generating long-term value for our shareholders," said Navid Mahmoodzadegan, Chief Executive Officer and Co-Founder.

*The Firm's revenues and net income can fluctuate materially depending on the number, size and timing of completed transactions as well as other factors. Accordingly, financial results in any particular quarter may not be representative of future results over a longer period of time.*

------

*Currently 92% of the operating partnership (Moelis & Company Group LP) is owned by the corporate partner (Moelis & Company) and is subject to corporate U.S. federal and state income tax. The remaining 8% is owned by other partners of Moelis & Company Group LP and is primarily subject to U.S. federal tax at the partner level (certain state, local and foreign income taxes are incurred at the company level). The Adjusted results included herein apply certain adjustments from our GAAP results, including the assumption that 100% of the Firm's operating result was taxed at our corporate effective tax rate. We believe the Adjusted results, when presented together with comparable GAAP results, are useful to investors to compare our performance across periods and to better understand our operating results. A reconciliation between our GAAP results and our Adjusted results is presented in the Appendix to this press release.*

**<u>GAAP and Adjusted (non-GAAP) Selected Financial Data (Unaudited)</u>**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **GAAP** | **GAAP** | **GAAP** | **Adjusted (non-GAAP)\*** | **Adjusted (non-GAAP)\*** | **Adjusted (non-GAAP)\*** |
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| **($ in thousands except per share data)** | **2026** | **2025** | **Variance** | **2026** | **2025** | **Variance** |
| Revenues | $319780 | $306593 | 4% | $319780 | $306593 | 4% |
| **Income (loss) before income taxes** | 46161 | 43053 | 7% | 47908 | 43053 | 11% |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision (benefit) for income taxes | 3866 | (10722) | N/M | 4795 | (11386) | N/M |
| **Net income (loss)** | 42295 | 53775 | -21% | 43113 | 54439 | -21% |
| Net income (loss) attributable to noncontrolling interests | 3862 | 3507 | 10% |  |  | N/M |
| Net income (loss) attributable to Moelis & Company | $38433 | $50268 | -24% | $43113 | $54439 | -21% |
| Diluted earnings (loss) per share | $0.48 | $0.64 | -25% | $0.50 | $0.64 | -22% |
| N/M = not meaningful |  |  |  |  |  |  |
| \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) |

---

**Revenues**

We earned revenues of $319.8 million in the first quarter of 2026, as compared with $306.6 million in the prior year period, representing an increase of 4%. The increase in first quarter revenues is primarily attributable to an increase in Private Capital Advisory and M&A revenues, partially offset by declines in Capital Structure Advisory and Capital Markets revenues, as compared with the prior year period.

We continue to execute on our growth strategy. Since our last earnings release, one Managing Director focused on private credit secondaries and one focused on Healthcare have joined the Firm. Six additional Managing Directors are committed to join throughout the year, including two in Capital Markets, two in London focused on Chemicals and Sponsors, and two hires in Energy and Private Capital Advisory.

**Expenses**

The following tables set forth information relating to the Firm's operating expenses.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **GAAP** | **GAAP** | **GAAP** | **Adjusted (non-GAAP)\*** | **Adjusted (non-GAAP)\*** | **Adjusted (non-GAAP)\*** |
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| **($ in thousands)** | **2026** | **2025** | **Variance** | **2026** | **2025** | **Variance** |
| **Expenses:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits | $210415 | $211549 | -1% | $210415 | $211549 | -1% |
| &nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp; % of revenues* | *65.8%* | *69.0%* |  | *65.8%* | *69.0%* |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-compensation expenses | $68869 | $58132 | 18% | $67186 | $58132 | 16% |
| &nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp; % of revenues* | *21.5%* | *19.0%* |  | *21.0%* | *19.0%* |  |
| Total operating expenses | $279284 | $269681 | 4% | $277601 | $269681 | 3% |
| &nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp; % of revenues* | *87.3%* | *88.0%* |  | *86.8%* | *88.0%* |  |
| \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) |

---

------

Total operating expenses on a GAAP basis were $279.3 million for the first quarter of 2026. On an Adjusted basis, total operating expenses were $277.6 million for the first quarter of 2026, as compared with $269.7 million in the prior year period. The increase in Adjusted operating expenses is attributable to increased non-compensation expenses, as compared with the prior year period.

Compensation and benefits expenses on a GAAP and Adjusted basis were $210.4 million for the first quarter of 2026, as compared with GAAP and Adjusted compensation and benefits expenses of $211.5 million in the prior year period. The marginal decline in compensation and benefits expense during the first quarter of 2026 is attributable to a lower incentive compensation accrual, as compared with the prior year period.

Non-compensation expenses on a GAAP basis were $68.9 million for the first quarter of 2026. On an Adjusted basis, non-compensation expenses were $67.2 million for the first quarter of 2026, as compared with $58.1 million in the prior year period. The increase in non-compensation expenses during the first quarter of 2026 is primarily attributable to an increase in deal-related costs and growth in communications and technology expenses, as compared with the prior year period.

**Other Income (Expenses)** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **GAAP** | **GAAP** | **GAAP** | **Adjusted (non-GAAP)\*** | **Adjusted (non-GAAP)\*** | **Adjusted (non-GAAP)\*** |
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| **($ in thousands)** | **2026** | **2025** | **Variance** | **2026** | **2025** | **Variance** |
| Other income (expenses) | $5665 | $6141 | -8% | $5728 | $6141 | -7% |
| \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) | \* See Appendix for a reconciliation of GAAP to Adjusted (non-GAAP) |  |  |  |

---

Other income on a GAAP basis was $5.7 million for the first quarter of 2026. On an Adjusted basis, other income was $5.7 million for the first quarter of 2026, as compared with $6.1 million in the prior year period.

**Provision for Income Taxes**

The corporate partner (Moelis & Company) currently owns 92% of the operating partnership (Moelis & Company Group LP) and is subject to corporate U.S. federal and state income tax on its allocable share of earnings. The remaining 8% of activity is subject to certain state, local and foreign income taxes (including New York City Unincorporated Business Tax), which is accounted for at the partner level through the noncontrolling interests. For Adjusted purposes, we have assumed that 100% of the Firm's first quarter 2026 operating results were taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of approximately $9.2 million; excluding such benefit, our effective tax rate for the first quarter of 2026 would have been 29.3%.

**Capital Management and Balance Sheet**

Moelis & Company continues to maintain a strong financial position, and as of March 31, 2026, we held cash and liquid investments of $353.7 million and had no debt on our balance sheet.

The Board of Directors of Moelis & Company declared a regular quarterly dividend of $0.65 per share. The $0.65 per share will be paid on June 18, 2026 to common stockholders of record on May 11, 2026. During the first quarter of 2026, we repurchased a total of 1.9 million shares for $117.3 million, including 1.0 million shares to settle tax liabilities at an average price of $62.83 per share and a quarterly record 0.9 million shares on the open market at an average price of $59.78 per share. Including the dividend declared today, we will have returned $171.4 million of capital to shareholders with respect to the first quarter of 2026.

------

**<u>Earnings Call</u>**

We will host a conference call beginning at 5:00pm ET on Wednesday, April 29, 2026, accessible via telephone and the internet. Navid Mahmoodzadegan, Chief Executive Officer and Co-Founder, and Chris Callesano, Chief Financial Officer, will review our first quarter 2026 financial results. Following the review, there will be a question and answer session.

Investors and analysts may participate in the live conference call by dialing 1-888-300-4150 (domestic) or 1-646-970-1530 (international) and using access code 8014191. Please dial in 15 minutes before the conference call begins. The conference call will also be accessible as a listen-only audio webcast through the Investor Relations section of the Moelis & Company website at www.moelis.com.

For those unable to listen to the live broadcast, a replay of the call will be available for one month via telephone starting approximately one hour after the live call ends. The replay can be accessed at 1-800-770-2030 (domestic) or 1-609-800-9909 (international); the conference number is 8014191.

**<u>About Moelis & Company</u>**

Moelis & Company is a leading global independent investment bank that provides innovative strategic advice and solutions to a diverse client base, including corporations, governments and financial sponsors. The Firm assists its clients in achieving their strategic goals by offering comprehensive integrated financial advisory services across all major industry sectors. Moelis & Company's experienced professionals advise clients on their most critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, private fund raisings and secondary transactions and other corporate finance matters. The Firm serves its clients from 23 locations in North and South America, Europe, the Middle East, and Asia-Pacific. For further information, please visit: www.moelis.com.

**<u>Forward-Looking Statements</u>**

This press release contains forward-looking statements, which reflect the Firm's current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "target," "approximately," "predicts," "intends," "plans," "estimates," "anticipates" or the negative version of these words or other comparable words. Such forward-looking statements are based on certain assumptions and estimates and subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. We believe these factors include, but are not limited to, those described under "Risk Factors" discussed in our Annual Report on Form 10-K for the year ended December 31, 2025, subsequent reports filed on Form 10-Q and our other filings with the SEC. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release. In addition, new risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results. The Firm undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

**<u>Non-GAAP Financial Measures</u>**

The Company prepares its consolidated financial statements using accounting principles generally accepted in the United States (GAAP). From time to time, the Company may disclose certain "non-GAAP financial measures" in the course of its earnings releases, earnings conference calls, financial presentations and otherwise. The Securities

------

and Exchange Commission defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position, or cash flows that is subject to adjustments that effectively exclude, or include amounts from the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures disclosed by the Company are provided as additional information to analysts, investors and other stakeholders in order to provide them with greater transparency about, or an alternative method for assessing our financial condition, operating results, or capital adequacy. Adjusted results are a non-GAAP financial measure which provide additional information on management's view of operating results. These measures are not in accordance with, or a substitute for GAAP, and may be different from or inconsistent with non-GAAP financial measures used by other companies. Whenever we refer to a non-GAAP financial measure, we will also generally define it or present the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.

The Company's Adjusted revenues may include amounts reflected within other income (expenses) which are considered the equivalent of revenues for compensation. Such adjustments may include gains on founder investments where our employees and the Moelis advisory platform contributed meaningfully to the value creation; or the mark-to-market impact of equity instruments held by the Company that were originally received as payment for our banking services and included in revenues. We believe these adjustments are useful to allow comparability of period-to-period operating performance and compensation levels.

The Company's Adjusted compensation and benefits expenses may include adjustments reflected within other income (expenses) associated with compensation awards forfeited or returned to the Company by former employees. Management views the credits associated with such forfeitures as an offset to compensation and benefits expenses since the Firm will utilize the forfeited economics to recruit and or retain talent. We believe the netted presentation of forfeiture credits and compensation expenses is useful to allow comparability of period-to-period operating performance.

The Company's Adjusted non-compensation expenses and other income (expenses) may exclude certain one-time items that reduce the comparability of our operating performance as well as the amounts related to revenues and compensation and benefits expenses discussed above and adjustments to our provision for income taxes discussed below. Such adjustments increase the comparability of our financial performance across reporting periods and versus our peers.

The Company's Adjusted provision (benefit) for income taxes is adjusted to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rates for the periods presented. Adjusted provision (benefit) for income taxes periodically includes the tax impact related to the settlement of share-based awards, the reclassification of TRA liability adjustments, or adjustments to our deferred tax assets and liabilities that occur in connection with new tax legislation. Such adjustments increase the comparability of our financial performance across reporting periods and versus our peers.

The Company's Adjusted basic and diluted shares of Class A common stock outstanding is presented for each period as if all outstanding Class A partnership units have been exchanged into Class A common stock. The Adjusted presentation helps analysts, investors, and other stakeholders understand the effect of the Firm's ownership structure on its results, including the impact of all the Firm's income becoming subject to corporate-level tax.

------

**<u>Contacts</u>**

---

| | |
|:---|:---|
| **Investor Contact:** | **Media Contact:** |
| Matt Tsukroff | Melissa Chiles |
| Moelis & Company | Moelis & Company |
| t: + 1 212 883 3800 | t: + 1 212 883 3583 |
| m: +1 917 526 2340  | <u>press@moelis.com</u> |
| <u>matthew.tsukroff@moelis.com</u> |  |

---

------

**Appendix**

GAAP Consolidated Statement of Operations (Unaudited)

Reconciliation of GAAP to Adjusted (non-GAAP) Financial Information (Unaudited)

------

**Moelis & Company**

**GAAP Consolidated Statement of Operations**

**Unaudited** 

**(dollars in thousands, except for share and per share data)**

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **2025** |
| **Revenues** | $319780 | $306593 |
| **Expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits | 210415 | 211549 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Occupancy | 10420 | 8117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professional fees | 6672 | 6914 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Communication, technology and information services | 15648 | 13321 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Travel and related expenses | 18402 | 17469 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 3493 | 2779 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other expenses | 14234 | 9532 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Expenses | 279284 | 269681 |
| **Operating income (loss)** | 40496 | 36912 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income (expenses) | 5665 | 6141 |
| **Income (loss) before income taxes** | 46161 | 43053 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision (benefit) for income taxes | 3866 | (10722) |
| **Net income (loss)** | 42295 | 53775 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to noncontrolling interests | 3862 | 3507 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Moelis & Company | $38433 | $50268 |
| Weighted-average shares of Class A common stock outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 75438451 | 73870456 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 79478003 | 78556091 |
| Net income (loss) attributable to holders of shares of Class A common stock per share |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.51 | $0.68 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.48 | $0.64 |

---

------

**Moelis & Company**

**Reconciliation of GAAP to Adjusted (non-GAAP) Financial Information**

**Unaudited** 

**(dollars in thousands, except share and per share data)** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| **Adjusted items** | **Adjusted items** | **GAAP** | **GAAP** | **Adjustments** | **Adjustments** | **Adjusted<br>(non-GAAP)** | **Adjusted<br>(non-GAAP)** |
| Non-compensation expenses | Non-compensation expenses | $| 68869 |  | (1683)<br> (a) | $| 67186 |
| Other income (expenses) | Other income (expenses) |  | 5665 |  | 63<br> (b) |  | 5728 |
| Income (loss) before income taxes | Income (loss) before income taxes |  | 46161 |  | 1746 |  | 47908 |
| Provision (benefit) for income taxes | Provision (benefit) for income taxes |  | 3866 |  | 929<br> (b)(c) |  | 4795 |
| Net income (loss) | Net income (loss) |  | 42295 |  | 817 |  | 43113 |
| Net income (loss) attributable to noncontrolling interests | Net income (loss) attributable to noncontrolling interests |  | 3862 |  | (3862)<br> (d) |  |  |
| Net income (loss) attributable to Moelis & Company | Net income (loss) attributable to Moelis & Company | $ | 38433 | $ | 4679 | $ | 43113 |
| Weighted-average shares of Class A common stock outstanding | Weighted-average shares of Class A common stock outstanding |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | &nbsp;&nbsp;&nbsp;&nbsp;Basic |  | 75438451 |  | 6735209<br> (d) |  | 82173660 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | &nbsp;&nbsp;&nbsp;&nbsp;Diluted |  | 79478003 |  | 6735209<br> (d) |  | 86213212 |
| Net income (loss) attributable to holders of shares of Class A common stock per share | Net income (loss) attributable to holders of shares of Class A common stock per share |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | &nbsp;&nbsp;&nbsp;&nbsp;Basic | $ | 0.51 |  |  | $ | 0.52 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $ | 0.48 |  |  | $ | 0.50 |
| (a) | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. | Reflects an adjustment of $1.7 million related to expenses for new United Kingdom office space under construction as of March 31, 2026. This duplicate expense will cease when the current location is vacated during the second quarter of 2026. |
| (b) | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. | Tax Receivable Agreement liability adjustments are made to other income (expenses) for GAAP purposes. Any adjustment related to the TRA liability is reclassified to the provision for income tax line and such adjustment for the period was an expense of $0.1 million. |
| (c) | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate of 10.0%. Our tax provision includes a tax benefit related to the settlement of share-based awards of $9.2 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.3%. Our Adjusted tax provision excludes the costs related to the adjustment to the TRA liabilities originated from past partnership unit exchanges of $0.1 million. |
| (d) | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. |

---

------

**Moelis & Company**

**Reconciliation of GAAP to Adjusted (non-GAAP) Financial Information**

**Unaudited** 

**(dollars in thousands, except share and per share data)** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| **Adjusted items** | **Adjusted items** | **GAAP** | **GAAP** | **Adjustments** | **Adjustments** | **Adjusted<br>(non-GAAP)** | **Adjusted<br>(non-GAAP)** |
| Income (loss) before income taxes | Income (loss) before income taxes | $| 43053 |  |  | $| 43053 |
| Provision (benefit) for income taxes | Provision (benefit) for income taxes |  | (10722) |  | (664)<br> (a) |  | (11386) |
| Net income (loss) | Net income (loss) |  | 53775 |  | 664 |  | 54439 |
| Net income (loss) attributable to noncontrolling interests | Net income (loss) attributable to noncontrolling interests |  | 3507 |  | (3507)<br> (b) |  |  |
| Net income (loss) attributable to Moelis & Company | Net income (loss) attributable to Moelis & Company | $ | 50268 | $ | 4171 | $ | 54439 |
| Weighted-average shares of Class A common stock outstanding | Weighted-average shares of Class A common stock outstanding |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | &nbsp;&nbsp;&nbsp;&nbsp;Basic |  | 73870456 |  | 6355291<br> (b) |  | 80225747 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | &nbsp;&nbsp;&nbsp;&nbsp;Diluted |  | 78556091 |  | 6355291<br> (b) |  | 84911382 |
| Net income (loss) attributable to holders of shares of Class A common stock per share | Net income (loss) attributable to holders of shares of Class A common stock per share |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | &nbsp;&nbsp;&nbsp;&nbsp;Basic | $ | 0.68 |  |  | $ | 0.68 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $ | 0.64 |  |  | $ | 0.64 |
| (a) | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. | An adjustment has been made to illustrate the result as if 100% of the Firm's income is being taxed at our corporate effective tax rate for the period stated. Our tax provision includes a tax benefit related to the settlement of share-based awards of $24.1 million; excluding such discrete benefit, our effective tax rate for the period presented would have been 29.5%. |
| (b) | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. | Assumes all outstanding Class A partnership units have been exchanged into Class A common stock. |

---

------